MESO
Price
$15.87
Change
-$0.44 (-2.70%)
Updated
Sep 26, 01:18 PM (EDT)
Capitalization
2.1B
61 days until earnings call
RAPT
Price
$25.29
Change
+$0.83 (+3.39%)
Updated
Sep 26, 01:25 PM (EDT)
Capitalization
404.35M
Interact to see
Advertisement

MESO vs RAPT

Header iconMESO vs RAPT Comparison
Open Charts MESO vs RAPTBanner chart's image
Mesoblast
Price$15.87
Change-$0.44 (-2.70%)
Volume$442
Capitalization2.1B
RAPT Therapeutics
Price$25.29
Change+$0.83 (+3.39%)
Volume$800
Capitalization404.35M
MESO vs RAPT Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. RAPT commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and RAPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (MESO: $16.31 vs. RAPT: $24.45)
Brand notoriety: MESO and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 58% vs. RAPT: 144%
Market capitalization -- MESO: $2.1B vs. RAPT: $404.35M
MESO [@Biotechnology] is valued at $2.1B. RAPT’s [@Biotechnology] market capitalization is $404.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both MESO and RAPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 8 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • MESO’s TA Score: 8 bullish, 2 bearish.
  • RAPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MESO is a better buy in the short-term than RAPT.

Price Growth

MESO (@Biotechnology) experienced а +3.56% price change this week, while RAPT (@Biotechnology) price change was +19.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

MESO is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($2.11B) has a higher market cap than RAPT($404M). RAPT YTD gains are higher at: 93.434 vs. MESO (-17.626). MESO has higher annual earnings (EBITDA): -73.66M vs. RAPT (-111.99M). RAPT (169M) and MESO (161M) have equal amount of cash in the bank . RAPT has less debt than MESO: RAPT (3.16M) vs MESO (128M). MESO has higher revenues than RAPT: MESO (17.2M) vs RAPT (0).
MESORAPTMESO / RAPT
Capitalization2.11B404M521%
EBITDA-73.66M-111.99M66%
Gain YTD-17.62693.434-19%
P/E RatioN/AN/A-
Revenue17.2M0-
Total Cash161M169M95%
Total Debt128M3.16M4,046%
FUNDAMENTALS RATINGS
MESO vs RAPT: Fundamental Ratings
MESO
RAPT
OUTLOOK RATING
1..100
8326
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3935
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
2850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RAPT's Valuation (77) in the null industry is in the same range as MESO (86) in the Biotechnology industry. This means that RAPT’s stock grew similarly to MESO’s over the last 12 months.

RAPT's Profit vs Risk Rating (100) in the null industry is in the same range as MESO (100) in the Biotechnology industry. This means that RAPT’s stock grew similarly to MESO’s over the last 12 months.

MESO's SMR Rating (96) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that MESO’s stock grew similarly to RAPT’s over the last 12 months.

RAPT's Price Growth Rating (35) in the null industry is in the same range as MESO (39) in the Biotechnology industry. This means that RAPT’s stock grew similarly to MESO’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that MESO’s stock grew similarly to RAPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESORAPT
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LMSQF0.150.01
+8.68%
Latin Metals Inc.
FSAEX14.31N/A
N/A
Fidelity Series All-Sector Equity
HSTAX91.47N/A
N/A
Hartford Stock HLS IA
HHULF18.62N/A
N/A
Hamburger Hafen Und Logistik Ag
CLLKF2.29N/A
N/A
BICO GROUP AB

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+0.31%
QTTB - MESO
51%
Loosely correlated
+0.53%
TNGX - MESO
33%
Poorly correlated
+2.18%
AVTX - MESO
32%
Poorly correlated
-0.43%
ZURA - MESO
32%
Poorly correlated
-8.30%
RAPT - MESO
30%
Poorly correlated
+2.09%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+2.09%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
+2.02%
TRAW - RAPT
45%
Loosely correlated
+1.08%
AGIO - RAPT
41%
Loosely correlated
-1.90%
KROS - RAPT
39%
Loosely correlated
+0.32%
More